Loading clinical trials...
Loading clinical trials...
This study aims to determine survival outcomes (overall survival and progression-free survival) of primary uterine malignancies in China and relevant risk factors in a prospective cohort study.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Lei Li
NCT06563245 · Classical Hodgkin Lymphoma, Child, and more
NCT07269041 · Liver Transplantation, Immune Tolerance, and more
NCT07046923 · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, and more
NCT05129969 · Ovarian Cancer, Endometrial Cancer, and more
NCT06751329 · Ovarian Neoplasms, Prostatic Neoplasms, and more
Lei Li
Beijing, China/Beiing
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions